Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Early pregnancy iron levels may flag diabetes risk

NCT ID NCT07433465

Diagnosis Sponsor: Zagazig University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether measuring ferritin (a marker of iron stores) in early pregnancy can help predict which women will later develop gestational diabetes. Researchers followed 556 pregnant women, measuring their ferritin and other blood markers early on. The goal was to see if high ferritin levels could identify high-risk women before diabetes develops, potentially allowing for earlier care and better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple blood test early in pregnancy to identify women at risk for gestational diabetes, allowing for earlier monitoring and lifestyle changes.
What could go wrong
This is an observational study, not a treatment trial. The findings need to be confirmed in larger, more diverse groups before any test is widely used. High ferritin may not be the only factor involved.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

556 people

The number who actually took part.

Started

Dec 2022

Finished

Oct 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pregnant women at the time of their initial pregnancy diagnosis, typically presenting at prenatal or outpatient clinics.

Ages

21 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Confirmed pregnancy at an early gestational age. * Provision of clinical and family history (e.g., age, BMI, history of GDM). Exclusion Criteria: * Pre-existing Type 1 or Type 2 Diabetes Mellitus. * Conditions known to significantly alter iron metabolism independent of pregnancy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes mellitus

Contacts and locations

Locations

  • Benha University

    Banhā, Al Qalyoubia, 13511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.